The radiopharmaceuticals market is projected to reach US$ 13,818.17 million by 2028 from US$ 7,550.74 million in 2021; it is expected to grow at a CAGR of 9.0% from 2021 to 2028.
The growth of the market is attributed to the rising prevalence of chronic diseases, suitability of alpha radioimmunotherapy in targeted cancer treatment, and advancements in nuclear imaging techniques. However, the short shelf-life of radiopharmaceuticals and availability of substitutes restrain the Radiopharmaceuticals market growth. A radiopharmaceutical is a drug that can be used either for diagnostic or therapeutic purposes. Radiopharmaceuticals are radioisotopes that are bound to biological molecules that target specific tissues, organs, or cells within the human body. Radioisotopes emitting gamma rays are useful for diagnostic imaging where the radiation escapes the body. These rays are detected by a specific device, which is usually single-photon emission computed tomography (SPECT)/positron emission tomography (PET) cameras.
The COVID-19 pandemic has profoundly changed hospital activities, including nuclear medicine (NM) practices across Europe. A literature search on PubMed was performed covering COVID-19 studies published up until January 2021. As per the findings, the pandemic strongly challenged NM departments, and a reduction in the workforce has been experienced in every center in Europe. To limit COVID-19 transmission, NM departments introduced restriction measures, such as the rescheduling of non-high-priority procedures. Also, a few of the departments experienced a delay in radiopharmaceuticals supply or technical assistance due to the pandemic. As a result, the crisis resulted in a significant reduction of diagnostic and therapeutic NM procedures and a reduced level of care for patients affected by diseases, such as cancer or acute cardiovascular disease.
Lucrative Regions for Radiopharmaceuticals Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Rising Prevalence of Chronic Diseases Fuels Radiopharmaceuticals Market Growth
The prevalence of chronic diseases such as cardiovascular diseases (CVDs), cancer, chronic lung diseases, stroke, Alzheimer’s disease, chronic kidney disease, and several neurological disorders is increasing rapidly across the world. These diseases are among the leading causes of death. As per the World Health Organization (WHO), cancer accounted for 10 million deaths in 2020 globally. Furthermore, as per the estimations of the American Cancer Society, 1,806,590 new cases of cancer were diagnosed in the US in 2020. As per the European Heart Network, CVDs cause 3.9 million deaths in Europe and more than 1.8 million deaths in the European Union (EU) every year. They account for 45.0% of total mortalities in Europe and 37.0% of the total death count in the EU. As per the American College of Cardiology, CVDs cause 800,000 death cases in the US every year. Coronary heart disease (CHD) contributes to a majority of CVD mortalities, followed by stroke and heart failure; 90 million Americans are diagnosed with CVDs per year. In addition, CVDs contribute to 31% of total death globally, and the cost burden of CVDs on healthcare systems is expected to be US$ 1,044 billion by 2030.
According to Emory Healthcare, in 2018, 5 million people suffer from congestive heart failure (CHF) in the US. Further, according to the WHO, ~1.71 billion people in the world are suffering from musculoskeletal conditions. An effective examination is a must for the treatment of chronic diseases, and nuclear substances are used for diagnosis and examination purposes; they are used in diagnostic tests such as positron emission tomography (PET) and single-photon emission computerized tomography (SPECT). Thus, with a surge in the incidence of chronic diseases, the need for radiopharmaceuticals is also increasing, thereby driving the market growth.
Type-Based Insights
Based on type, the radiopharmaceuticals market is bifurcated into diagnostic nuclear medicine and therapeutic nuclear medicine. The diagnostic nuclear medicine segment is holding a larger share of the market and is expected to register a higher CAGR during 2021–2028. The radioisotope used widely in diagnostic nuclear medicine is technetium-99m. The radioisotope attaches to several specific molecules, allowing the diagnosis of various diseases, such as the certain types of cancers. For instance, technetium-99m-MDP (methylene diphosphonate) is widely used to detect bone metastasis associated with cancer.
Radiopharmaceuticals Market, by Type – 2021 and 2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Product Type-Based Insights
Based on product type, the radiopharmaceuticals market is segmented into Technetium-99m, Thallium-201, Gallium-67, Iodine-131, Copper-64, and other. The Technetium-99m segment is holding the largest share of the market, whereas the gallium-67 segment is expected to register the highest CAGR during 2021–2028. Gallium-67 is used for the imaging and localization of inflammatory lesions (infections). Gallium-67 is an injectable radiopharmaceutical that is used with single photon emission computed tomography (SPECT) to detect the presence of acute inflammatory lesions and various malignancies, such as Hodgkin’s disease, lymphomas, and bronchogenic carcinomas.
Application-Based Insights
Based on application, the radiopharmaceuticals market is segmented into oncology, cardiology, neurology, and others. The oncology segment is holding the largest share of the market. The market growth for this segment can be attributed to the increasing incidence of cancer worldwide. Cancer is one of the significant health problems with a high mortality rate. It is a threat to global health. As per the WHO, in 2018, an estimated 18 million new cancer cases were diagnosed worldwide, and 9.6 million people died from cancer. However, the market for the cardiology segment is expected to grow at the fastest rate in the coming years.
End User-Based Insights
Based on end user, the radiopharmaceuticals market is segmented into hospitals, imaging centers, academic and research centers, and others. In 2021, the hospitals segment is holding the largest share of the market. The market growth for this segment can be attributed to the rising prevalence of chronic diseases, increasing number of hospitals across the world, and rapidly growing number of surgical procedures. However, the market for the diagnostic centers segment is expected to grow at the fastest rate in the coming years.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Radiopharmaceuticals Market: Strategic Insights
Market Size Value in US$ 7,550.74 Million in 2021 Market Size Value by US$ 13,818.17 Million by 2028 Growth rate CAGR of 9.0% from 2021-2028 Forecast Period 2021-2028 Base Year 2021
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Radiopharmaceuticals Market: Strategic Insights
| Market Size Value in | US$ 7,550.74 Million in 2021 |
| Market Size Value by | US$ 13,818.17 Million by 2028 |
| Growth rate | CAGR of 9.0% from 2021-2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Companies operating in the radiopharmaceuticals market are adopting the product innovations strategy to meet the evolving customer demands across the world, which also permits them to maintain their brand name in the global market.
Radiopharmaceuticals Market – by Type
- Diagnostic Nuclear Medicine
- SPECT Radiopharmaceuticals
- PET Radiopharmaceuticals
- Therapeutic Nuclear Medicine
- Alpha Emitters
- Beta Emitters
- Brachytherapy Isotopes
Radiopharmaceuticals Market – by Product Type
- Technetium-99m
- Thallium-201
- Gallium-67
- Iodine-131
- Copper-64
- Other
Radiopharmaceuticals Market – by Application
- Oncology
- Cardiology
- Neurology
- Others
Radiopharmaceuticals Market – by End User
- Hospitals
- Imaging Centers
- Academic and Research Centers
- Others
Radiopharmaceuticals Market– by Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of APAC
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
- South and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Company Profiles
- Cardinal Health
- GE Healthcare
- Curium
- Lantheus Medical Imaging
- Bayer AG
- Bracco Imaging
- Eczacýbaþý-Monrol Nuclear Products
- Nordion
- Advanced Accelerator Applications
- NTP Radioisotopes
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type , Product Type , Application , and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, RoAPAC, RoE, RoMEA, RoSCAM, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Radiopharmaceuticals are radioisotopes that are bound to biological molecules that target specific tissues, organs, or cells within the human body. Radioisotopes emitting gamma rays are useful for diagnostic imaging where the radiation escapes the body. These rays are detected by a specific device, which is usually single-photon emission computed tomography (SPECT)/ positron emission tomography (PET) cameras.
The factors that are driving growth of the market are rising prevalence of chronic diseases, suitability of alpha radioimmunotherapy in targeted cancer treatment, and advancements in nuclear imaging techniques.
Various companies have made organic growth strategies in the Radiopharmaceuticals Market. Some of the activities undertaken by the company, which have promoted its growth are, launches, enhancements and expansion & relocation activities. Companies such as Lantheus Medical Imaging, Inc., Bracco Imaging S.p.A, Advanced Accelerator Applications amongst others are some of the companies that have been implementing various organic strategies that have helped the growth of the company.
North America dominates the global radiopharmaceuticals market due to factors such as technological advancement, increasing product launches, well-developed healthcare facility centres equipped with modern-age equipment and instruments.
The diagnostic nuclear medicine segment is growing at the highest CAGR owing to availability of diagnostic devices and ease offered by these devices for diagnosis of various disorders. Also, nuclear medicine provides better diagnostic information about the functioning of a specific organ, as it uses radiation.
Asia Pacific is expected to be the fastest growing region in the radiopharmaceuticals market. The growth of the market in this region is primarily due to prevalence of stroke and other neurological disorders along with the presence of supportive government initiatives and research in the field of radiopharmaceuticals.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Radiopharmaceuticals Market – By Type
1.3.2 Global Radiopharmaceuticals Market – By Product Type
1.3.3 Global Radiopharmaceuticals Market – By Application
1.3.4 Global Radiopharmaceuticals Market – By End User
1.3.5 Global Radiopharmaceuticals Market– By Geography
2. Global Radiopharmaceuticals Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Radiopharmaceuticals Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe– PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East and Africa – PEST Analysis
4.2.5 South and Central America (SCAM) – PEST Analysis
4.3 Experts Opinion
5. Radiopharmaceuticals Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Chronic Diseases
5.1.2 Suitability of Alpha Radioimmunotherapy in Targeted Cancer Treatment
5.1.3 Advancements in Nuclear Imaging Techniques
5.2 Market Restraints
5.2.1 Short Shelf-Life of Radiopharmaceuticals
5.2.2 Availability of Substitutes
5.3 Market Opportunities
5.3.1 High Growth Potential in Developing Countries
5.4 Future Trends
5.4.1 Use of Nuclear Medicine for Personalized Treatment
5.5 Impact Analysis
6. Radiopharmaceuticals Market– Global Analysis
6.1 Global Radiopharmaceuticals Market Revenue Forecast and Analysis
6.2 Global Radiopharmaceuticals Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Radiopharmaceuticals Market Analysis – By Type
7.1 Overview
7.2 Radiopharmaceuticals Market Revenue Share, by Type (2021 and 2028)
7.3 Diagnostic Nuclear Medicine
7.3.1 Overview
7.3.2 Diagnostic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 (Single-Photon Emission Computed Tomography) Applications
7.3.3.1 Overview
7.3.3.2 SPECT (Single-Photon Emission Computed Tomography) Applications: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 PET (Positron Emission Tomography) Applications
7.3.4.1 Overview
7.3.4.2 PET (Positron Emission Tomography) Applications: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Therapeutic Nuclear Medicine
7.4.1 Overview
7.4.2 Therapeutic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Alpha Emitters
7.4.3.1 Overview
7.4.3.2 Alpha Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4 Beta Emitters
7.4.4.1 Overview
7.4.4.2 Beta Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
7.4.5 Brachytherapy Isotopes
7.4.5.1 Overview
7.4.5.2 Brachytherapy Isotopes: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
8. Radiopharmaceuticals Market Analysis – By Product Type
8.1 Overview
8.2 Radiopharmaceuticals Market Revenue Share, by Product Type (2021 and 2028)
8.3 Iodine-131
8.3.1 Overview
8.3.2 Iodine-131: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Gallium-67
8.4.1 Overview
8.4.2 Gallium-67: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Thallium-201
8.5.1 Overview
8.5.2 Thallium-201: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Technetium-99m
8.6.1 Overview
8.6.2 Technetium-99m: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Copper-64
8.7.1 Overview
8.7.2 Copper-64: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Other
8.8.1 Overview
8.8.2 Other: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
9. Radiopharmaceuticals Market Analysis – By Application
9.1 Overview
9.2 Radiopharmaceuticals Market Revenue Share, by Application (2021 and 2028)
9.3 Oncology
9.3.1 Overview
9.3.2 Oncology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Cardiology
9.4.1 Overview
9.4.2 Cardiology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Neurology
9.5.1 Overview
9.5.2 Neurology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
10. Radiopharmaceuticals Market Analysis – By End User
10.1 Overview
10.2 Radiopharmaceuticals Market Share, by End User, 2021 and 2028, (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Imaging Centres
10.4.1 Overview
10.4.2 Imaging Centres: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
10.5 Academic and Research Centers
10.5.1 Overview
10.5.2 Academic and Research Centers: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
11. Global Radiopharmaceuticals Market – Geographic Analysis
11.1 North America: Radiopharmaceuticals Market
11.1.1 Overview
11.1.2 North America: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
11.1.3 North America: Radiopharmaceuticals Market, by Type, 2019–2028 (USD Million)
11.1.3.1 North America: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)
11.1.3.2 North America: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)
11.1.4 North America: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)
11.1.5 North America: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)
11.1.6 North America: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)
11.1.6.1 US: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)
11.1.6.1.1 US: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
11.1.6.1.2 US: Radiopharmaceuticals Market, by Type, 2019–2028 (USD Million)
11.1.6.1.2.1 US: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)
11.1.6.1.2.2 US: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)
11.1.6.1.3 US: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)
11.1.6.1.4 US: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)
11.1.6.2 Canada: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
11.1.6.2.1 Canada: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
11.1.6.2.2 Canada: Radiopharmaceuticals Market, by Type, 2019–2028 (USD Million)
11.1.6.2.2.1 North America: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)
11.1.6.2.2.2 North America: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)
11.1.6.2.3 Canada: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)
11.1.6.2.4 Canada: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)
11.1.6.3 Mexico: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
11.1.6.3.1 Mexico: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
11.1.6.3.2 Mexico: Radiopharmaceuticals Market, by Type – 2019–2028 (USD Million)
11.1.6.3.2.1 Mexico: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)
11.1.6.3.2.2 Mexico: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)
11.1.6.3.3 Mexico: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)
11.1.6.3.4 Mexico: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)
11.2 Europe: Radiopharmaceuticals Market
11.2.1 Overview
11.2.2 Europe: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (USD Million)
11.2.3 Europe: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)
11.2.3.1 Europe: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)
11.2.3.2 Europe: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)
11.2.4 Europe: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)
11.2.5 Europe: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)
11.2.6 Europe: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)
11.2.6.1 Germany: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
11.2.6.1.1 Germany: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
11.2.6.1.2 Germany: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)
11.2.6.1.2.1 Germany: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)
11.2.6.1.2.2 Germany: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)
11.2.6.1.3 Germany: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)
11.2.6.1.4 Germany: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)
11.2.6.2 France: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
11.2.6.2.1 France: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
11.2.6.2.2 France: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)
11.2.6.2.2.1 France: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)
11.2.6.2.2.2 France: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)
11.2.6.2.3 France: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)
11.2.6.2.4 France: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)
11.2.6.3 UK: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
11.2.6.3.1 UK: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
11.2.6.3.2 UK: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)
11.2.6.3.2.1 UK: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)
11.2.6.3.2.2 UK: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)
11.2.6.3.3 UK: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)
11.2.6.3.4 UK: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)
11.2.6.4 Italy: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
11.2.6.4.1 Italy: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
11.2.6.4.2 Italy: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)
11.2.6.4.2.1 Italy: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)
11.2.6.4.2.2 Italy: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)
11.2.6.4.3 Italy: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)
11.2.6.4.4 Italy: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)
11.2.6.5 Spain: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
11.2.6.5.1 Spain: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
11.2.6.5.2 Spain: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)
11.2.6.5.2.1 Spain: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)
11.2.6.5.2.2 Spain: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)
11.2.6.5.3 Spain: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)
11.2.6.5.4 Spain: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)
11.2.6.6 Rest of Europe: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
11.2.6.6.1 Rest of Europe: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
11.2.6.6.2 Rest of Europe: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)
11.2.6.6.2.1 Rest of Europe: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)
11.2.6.6.2.2 Rest of Europe: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)
11.2.6.6.3 Rest of Europe: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)
11.2.6.6.4 Rest of Europe: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)
11.3 Asia Pacific: Radiopharmaceuticals Market
11.3.1 Overview
11.3.2 Asia Pacific: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (USD Million)
11.3.3 Asia Pacific: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)
11.3.3.1 Asia Pacific: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)
11.3.3.2 Asia Pacific: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)
11.3.4 Asia Pacific: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)
11.3.5 Asia Pacific: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)
11.3.6 Asia Pacific: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)
11.3.6.1 China: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
11.3.6.1.1 China: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
11.3.6.1.2 China: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)
11.3.6.1.2.1 China: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)
11.3.6.1.2.2 China: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)
11.3.6.1.3 China: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)
11.3.6.1.4 China: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)
11.3.6.2 Japan: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
11.3.6.2.1 Japan: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
11.3.6.2.2 Japan: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)
11.3.6.2.2.1 Japan: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)
11.3.6.2.2.2 Japan: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)
11.3.6.2.3 Japan: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)
11.3.6.2.4 Japan: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)
11.3.6.3 India: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
11.3.6.3.1 India: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
11.3.6.3.2 India: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)
11.3.6.3.2.1 India: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)
11.3.6.3.2.2 India: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)
11.3.6.3.3 India: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)
11.3.6.3.4 India: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)
11.3.6.4 Australia: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
11.3.6.4.1 Australia: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
11.3.6.4.2 Australia: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)
11.3.6.4.2.1 Australia: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)
11.3.6.4.2.2 Australia: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)
11.3.6.4.3 Australia: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)
11.3.6.4.4 Australia: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)
11.3.6.5 South Korea: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
11.3.6.5.1 South Korea: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
11.3.6.5.2 South Korea: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)
11.3.6.5.2.1 South Korea: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)
11.3.6.5.2.2 South Korea: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)
11.3.6.5.3 South Korea: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)
11.3.6.5.4 South Korea: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)
11.3.6.6 Rest of Asia Pacific: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
11.3.6.6.1 Rest of Asia Pacific: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
11.3.6.6.2 Rest of Asia Pacific: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)
11.3.6.6.2.1 Rest of Asia Pacific: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)
11.3.6.6.2.2 Rest of Asia Pacific: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)
11.3.6.6.3 Rest of Asia Pacific: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)
11.3.6.6.4 Rest of Asia Pacific: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)
11.4 Middle East and Africa: Radiopharmaceuticals Market
11.4.1 Overview
11.4.2 Middle East & Africa: Radiopharmaceuticals Market- Revenue and Forecast to 2028 (US$ Million)
11.4.3 Middle East and Africa Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)
11.4.3.1 Middle East and Africa: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)
11.4.3.2 Middle East and Africa: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)
11.4.4 Middle East and Africa Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
11.4.5 Middle East and Africa Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)
11.4.6 Middle East and Africa: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)
11.4.6.1 Saudi Arabia: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)
11.4.6.1.1 Saudi Arabia: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)
11.4.6.1.2 Saudi Arabia Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)
11.4.6.1.2.1 Saudi Arabia: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)
11.4.6.1.2.2 Saudi Arabia: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)
11.4.6.1.3 Saudi Arabia Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
11.4.6.1.4 Saudi Arabia Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)
11.4.6.2 UAE: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)
11.4.6.2.1 UAE: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)
11.4.6.2.2 UAE Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)
11.4.6.2.2.1 UAE: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)
11.4.6.2.2.2 UAE a: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)
11.4.6.2.3 UAE Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
11.4.6.2.4 UAE Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.4.6.3 South Africa: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)
11.4.6.3.1 South Africa: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)
11.4.6.3.2 South Africa Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)
11.4.6.3.2.1 South Africa: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)
11.4.6.3.2.2 South Africa: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)
11.4.6.3.3 South Africa Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
11.4.6.3.4 South Africa Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.4.6.4 Rest of Middle East and Africa: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)
11.4.6.4.1 Rest of Middle East and Africa: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)
11.4.6.4.2 Rest of Middle East and Africa Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)
11.4.6.4.2.1 Rest of Middle East and Africa: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)
11.4.6.4.2.2 Rest of Middle East and Africa: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)
11.4.6.4.3 Rest of Middle East and Africa Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
11.4.6.4.4 Rest of Middle East and Africa Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)
11.5 South and Central America: Radiopharmaceuticals Market
11.5.1 Overview
11.5.2 South and Central America: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)
11.5.3 South and Central America Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)
11.5.3.1 South and Central America: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)
11.5.3.2 South and Central America: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)
11.5.4 South and Central America Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
11.5.5 South and Central America Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)
11.5.6 South and Central America: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)
11.5.6.1 Brazil: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)
11.5.6.1.1 Brazil: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)
11.5.6.1.2 Brazil Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)
11.5.6.1.2.1 Brazil: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)
11.5.6.1.2.2 Brazil: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)
11.5.6.1.3 Brazil Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
11.5.6.1.4 Brazil Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)
11.5.6.2 Argentina: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)
11.5.6.2.1 Argentina: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)
11.5.6.2.2 Argentina Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)
11.5.6.2.2.1 Argentina: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)
11.5.6.2.2.2 Argentina: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)
11.5.6.2.3 Argentina Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
11.5.6.2.4 Argentina Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)
11.5.6.3 Rest of South and Central America: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)
11.5.6.3.1 Rest of South and Central America: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)
11.5.6.3.2 Rest of South and Central America Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)
11.5.6.3.2.1 Rest of South and Central America: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)
11.5.6.3.2.2 Rest of South and Central America: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)
11.5.6.3.3 Rest of South and Central America Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
11.5.6.3.4 Rest of South and Central America Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)
12. Impact Of COVID-19 Pandemic on Radiopharmaceuticals Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
12.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
12.5 South & Central America: Impact Assessment of COVID-19 Pandemic
13. Radiopharmaceuticals Market–Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Inorganic Growth Strategies
13.3.1 Overview
13.4 Organic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 Cardinal Health Inc
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Curium
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 GENERAL ELECTRIC
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Lantheus Medical Imaging, Inc.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Bayer AG
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Bracco Imaging S.p.A
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 ECZACIBA?I MONROL NUCLEAR PRODUCTS CO.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Nordion
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 NTP RADIOISOTOPES
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Advanced Accelerator Applications
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. Principal Radionuclides Used in Diagnostic Radiopharmaceuticals
Table 2. North America Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 3. North America Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 4. North America Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 5. North America Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 6. North America Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 7. US Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 8. US Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 9. US Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 10. US Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 11. US Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 12. Canada Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 13. North America Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 14. North America Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 15. Canada Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 16. Canada Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 17. Mexico Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 18. Mexico Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 19. Mexico Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 20. Mexico Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 21. Mexico Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 22. Europe: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 23. Europe Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 24. Europe Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 25. Europe Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 26. Europe Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 27. Germany: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 28. Germany Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 29. Germany Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 30. Germany: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 31. Germany: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 32. France: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 33. France Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 34. France Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 35. France: Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 36. France: Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 37. UK: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 38. UK Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 39. UK Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 40. UK: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 41. UK: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 42. Italy: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 43. Italy Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 44. Italy Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 45. Italy: Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 46. Italy: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 47. Spain: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 48. Spain Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 49. Spain Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 50. Spain: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 51. Spain: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 52. Rest of Europe: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 53. Rest of Europe Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 54. Rest of Europe Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 55. Rest of Europe: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 56. Rest of Europe: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 57. Asia Pacific: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 58. Asia Pacific Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 59. Asia Pacific Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 60. Asia Pacific Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 61. Asia Pacific Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 62. China: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 63. China Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 64. China Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 65. China: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 66. China: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 67. Japan: Radiopharmaceuticals Market, By Type– Revenue and Forecast to 2028 (USD Million)
Table 68. Japan Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 69. Japan Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 70. Japan: Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 71. Japan: Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 72. India: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 73. India Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 74. India Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 75. India: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 76. India: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 77. Australia: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 78. Australia Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 79. Australia Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 80. Australia: Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 81. Australia: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 82. South Korea: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 83. South Korea Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 84. South Korea Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 85. South Korea: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 86. South Korea: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 87. Rest of Asia Pacific: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 88. Rest of Asia Pacific Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 89. Rest of Asia Pacific Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 90. Rest of Asia Pacific: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 91. Rest of Asia Pacific: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 92. Middle East and Africa Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 93. Middle East and Africa Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 94. Middle East and Africa Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 95. Middle East and Africa Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 96. Middle East and Africa Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 97. Saudi Arabia Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 98. Saudi Arabia Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 99. Saudi Arabia Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 100. Saudi Arabia Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 101. Saudi Arabia Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 102. UAE Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 103. UAE Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 104. UAE Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 105. UAE Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 106. UAE Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 107. South Africa Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 108. South Africa Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 109. South Africa Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 110. South Africa Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 111. South Africa Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 112. Rest of Middle East and Africa Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 113. Rest of Middle East and Africa Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 114. Rest of Middle East and Africa Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 115. Rest of Middle East and Africa Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 116. Rest of Middle East and Africa Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 117. South and Central America Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 118. South and Central America Africa Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 119. South and Central America Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 120. South and Central America Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 121. South and Central America Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 122. Brazil Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 123. Brazil Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 124. Brazil Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 125. Brazil Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 126. Brazil Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 127. Argentina Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 128. Argentina Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 129. Argentina Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 130. Argentina Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 131. Argentina Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 132. Rest of South and Central America Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 133. Rest of South and Central America Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 134. Rest of South and Central America Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 135. Rest of South and Central America Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 136. Rest of South and Central America Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 137. Recent Inorganic Growth Strategies in the Radiopharmaceuticals Market
Table 138. Recent Organic Growth Strategies in the Radiopharmaceuticals Market
Table 139. Glossary of Terms, Radiopharmaceuticals Market
LIST OF FIGURES
Figure 1. Radiopharmaceuticals Market Segmentation
Figure 2. Radiopharmaceuticals Market Segmentation, By Region
Figure 3. Global Radiopharmaceuticals Market Overview
Figure 4. Diagnostic Nuclear Medicine Segment Held the Largest Share of the Type Segment in Radiopharmaceuticals Market
Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
Figure 6. Radiopharmaceuticals Market, by Geography (US$ Million)
Figure 7. Global Radiopharmaceuticals Market– Leading Country Markets (US$ Million)
Figure 8. Global Radiopharmaceuticals Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe and PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. Radiopharmaceuticals Market Impact Analysis of Drivers and Restraints
Figure 15. Global Radiopharmaceuticals Market– Revenue Forecast and Analysis – 2020- 2028
Figure 16. Global Radiopharmaceuticals Market – By Geography Forecast and Analysis – 2021- 2028
Figure 17. Market Positioning of Key Players in Global Radiopharmaceuticals Market
Figure 18. Radiopharmaceuticals Market Revenue Share, by Type (2021 and 2028)
Figure 19. Diagnostic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. SPECT (Single-Photon Emission Computed Tomography) Applications: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. PET (Positron Emission Tomography) Applications: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Therapeutic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Alpha Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Beta Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Brachytherapy Isotopes: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Radiopharmaceuticals Market Revenue Share, by Product Type (2021 and 2028)
Figure 27. Iodine-131: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Gallium-67: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Thallium-201: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Technetium-99m: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Copper-64: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Other: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Radiopharmaceuticals Market Revenue Share, by Application (2021 and 2028)
Figure 34. Oncology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Cardiology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Neurology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. Radiopharmaceuticals Market Share, by End User, 2021 and 2028 (%)
Figure 39. Hospitals: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. Imaging Centres: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. Academic and Research Centers: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. North America: Radiopharmaceuticals Market, by Key Country – Revenue (2021) (USD Million)
Figure 44. North America Radiopharmaceuticals Market Revenue and Forecast to 2028 (USD Million)
Figure 45. North America: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)
Figure 46. US: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
Figure 47. Canada: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
Figure 48. Mexico: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
Figure 49. Europe: Radiopharmaceuticals Market, by Key Country – Revenue (2021) (USD Million)
Figure 50. Europe Radiopharmaceuticals Market Revenue and Forecast to 2028 (USD Million)
Figure 51. Europe: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)
Figure 52. Germany: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
Figure 53. France: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
Figure 54. UK: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
Figure 55. Italy: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
Figure 56. Spain: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
Figure 57. Rest of Europe: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
Figure 58. Asia Pacific: Radiopharmaceuticals Market, by Key Country – Revenue (2021) (USD Million)
Figure 59. Asia Pacific Radiopharmaceuticals Market Revenue and Forecast to 2028 (USD Million)
Figure 60. Asia Pacific: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)
Figure 61. China: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
Figure 62. Japan: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
Figure 63. India: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
Figure 64. Australia: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
Figure 65. South Korea: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
Figure 66. Rest of Asia Pacific: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
Figure 67. Middle East and Africa: Radiopharmaceuticals Market, by Key Country – Revenue (2021) (USD Million)
Figure 68. Middle East & Africa Radiopharmaceuticals Market Revenue and Forecast to 2028 (US$ Million)
Figure 69. Middle East and Africa: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)
Figure 70. Saudi Arabia: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)
Figure 71. UAE: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)
Figure 72. South Africa: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)
Figure 73. Rest of Middle East and Africa: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)
Figure 74. South and Central America: Radiopharmaceuticals Market, by Key Country – Revenue (2021) (USD Million)
Figure 75. South and Central America Radiopharmaceuticals Market Revenue and Forecast to 2028 (USD Million)
Figure 76. South and Central America: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)
Figure 77. Brazil: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)
Figure 78. Argentina: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)
Figure 79. Rest of South and Central America: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)
Figure 80. Impact of COVID-19 Pandemic in North American Country Markets
Figure 81. Impact of COVID-19 Pandemic in European Country Markets
Figure 82. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 83. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 84. Impact of COVID-19 Pandemic in South & Central America Market
Figure 85. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Radiopharmaceuticals Market
- Cardinal Health
- GE Healthcare
- Curium
- Lantheus Medical Imaging
- Bayer AG
- Bracco Imaging
- Eczacýbaþý-Monrol Nuclear Products
- Nordion
- Advanced Accelerator Applications
- NTP Radioisotopes
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Radiopharmaceuticals Market
Aug 2021
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2021
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Aug 2021
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Aug 2021
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2021
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2021
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Aug 2021
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Aug 2021
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)